The Visionary: Shannon McWeeney, PhD

Back to All Stories

Cancer
July 19, 2019
Shannon McWeeney, PhD

Solving some of cancer’s most challenging riddles requires the ability to see the big picture. Luckily, this is something that Shannon McWeeney, PhD, is exceedingly good at.

As the head of bioinformatics and computational biology and associate director of computational biomedicine, McWeeney and her team helped to create a new data visualization platform called Vizome. The platform takes massive amounts of data and turns it into easily interpretable information to help facilitate new breakthroughs.

The need for such a platform became apparent during a study of acute myeloid leukemia. It was the largest study of its kind, generating so much data that it had potential to overwhelm scientists and clinicians. “Our goal was to develop a new approach to manage, integrate and visualize data in a way that would fuel exploration,” she said. “The last thing we wanted to do was isolate them from knowledge discovery.”

Help more patients survive more cancers.

Make a gift

Many times after large datasets are created, they sit in limbo because there are barriers created by their size or complexity. “Vizome removes this research bottleneck so we can accelerate biomedical research more quickly,” she explained.

McWeeney didn’t always plan to go into cancer research. She was originally focused on modelingmarine ecosystems. Then one summer, she attended a seminar about population genetics and disease applications. “That’s when I realized that my true north was no longer marine ecology,” she admitted.

Shifting gears, she went to University of California, Berkeley, and studied statistical genetics to focus on complex diseases. Then it was off to the University of Pennsylvania to study computational biology.

"When we're assembling a team, our goal is to have it be as diverse as possible. When we get too narrow, we start to lose sight of the bigger picture.” 

In the midst of all this, her mother was diagnosed with breast cancer.

“That was really a turning point. Suddenly, cancer became very personal,” she said. McWeeney accepted a position at the Knight Cancer Institute and began working on ways to combat drug resistance in cancer patients. She also studies cancer drugs that already have been approved and figures out ways to repurpose them for new treatments.

“It’s all about looking at what’s already in our arsenal and thinking about how they can work in other ways,” she said.

While McWeeney’s accomplishments have earned her an impressive list of awards, she is quick to point out that she doesn’t do it for the accolades. “All of this is for the patients,” she smiled. “None of it is for me.”

 

We believe in a world free from the burden of cancer.

Your gift will fuel cancer research, so we can help more patients survive more cancers.

GIVE NOW  LEARN MORE

Category: Cancer

Also In This Series!

Amanda Bruegl, MD
Part 1 of 9 | Forces of Change

Forces of Change

Kimberly Beatty, PhD
Part 2 of 9 | Forces of Change

The Mentor: Kimberly Beatty, PhD

Anupriya Agarwal, PhD
Part 3 of 9 | Forces of Change

The Independent: Anupriya Agarwal, PhD

Shannon McWeeney, PhD
Currently Viewing | Forces of Change

The Visionary: Shannon McWeeney, PhD

Missy Wong, PhD
Part 5 of 9 | Forces of Change

The Seeker: Missy Wong, PhD

Amanda Lund, PhD
Part 6 of 9 | Forces of Change

The Challenger: Amanda Lund, PhD

Amanda Bruegl, MD
Part 7 of 9 | Forces of Change

The Advocate: Amanda Bruegl, MD

Lara Davis, MD
Part 8 of 9 | Forces of Change

The Crusader: Lara Davis, MD

Beverly Emerson, PhD
Part 9 of 9 | Forces of Change

The Optimist: Beverly Emerson, PhD

Onward E-News

Sign up to receive our latest campaign news, updates and stories in your inbox

X
loading animation

We use cookies to ensure that we give you the best experience on our website. By continuing to use this site you consent to the use of cookies on your device as described in our privacy policy. You can change your cookies settings at any time through your browser settings.